The role of excipients in the stability of a loperamide formulation
Pharmaceutical Communications · 2024
DOI: 10.55627/pharma.003.002.01087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Communications, 2024. Verfasst von Sagheer Ahmed. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
For heart valves and stents, biomaterials based on metals, including alloys based on titanium and cobalt-chromium, provide mechanical support and resistance from corrosion (K. Sangeetha 2018, Muhammad Asad 2023). Benefits of biomaterials made up of polymers include enhanced biocompatibility (Adrian JT. Teo 2016, Daniel Salthouse 2023), regeneration of tissue (B.L. Seal 2001), and replication of the cardiovascular system's extracellular matrix (ECM) (Joseph M. Aamodt 2016). Bioprosthetic valves and allografts are biocompatible natural materials(Christine E. Schmidt 2000, Diana Elena Ciolacu 2022a), whereas biomimetic and physical surface modifications increase performance and biocompatibility, decreasing thrombosis, inflammation, and improving endothelialization (Megan Douglass 2022, Amisha S. Raikar 2023). In terms of biomedical devices, new developments such as biodegradable stents provide short-term support for weakened or constricted blood vessels, hence lowering the risks of serious cardiovascular events (Tingzhang Hu 2018).
Zitieren
APA
Ahmed, S. (2024). The role of excipients in the stability of a loperamide formulation. Pharmaceutical Communications. https://doi.org/10.55627/pharma.003.002.01087
Vancouver
Ahmed S. The role of excipients in the stability of a loperamide formulation. Pharmaceutical Communications. 2024. doi:10.55627/pharma.003.002.01087
BibTeX
@article{Ahmed2024,
author = {Ahmed, Sagheer},
title = {The role of excipients in the stability of a loperamide formulation},
journal = {Pharmaceutical Communications},
year = {2024},
doi = {10.55627/pharma.003.002.01087}
}
EUVIMED